Az intrathecalis baclofenkezelés tapasztalatai agyká rosodást szenvedett, spasticus felno{combining double acute accent}tt betegek esetében

Translated title of the contribution: Results of intrathecal baclofen therapy on spasticity in patients with brain injury

Zoltán Dénes, András Klauber, Béla Both, L. Erőss

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives - To evaluate the results of intrathecal baclofen (ITB) therapy on the spasticity in patients with brain injury. Method - Retrospective study in Brain Injury Rehabilitation Unit between January 2001 and December 2010. Results - During the last ten years, in our unit 13 patients were involved into ITB therapy on severe spasticity, after brain injury, while more than 100 Baclofen pumps were implantated in Hungary with Hungary with coordination of the Multidisciplinary Team. ITB therapy was indicated in severe spasticity developed after seven cases of traumatic brain injuries, five cases of strokes and one case of anoxic brain injury. The mean age of patients was 26 years (18-52). At the time of pump implantation three patients were in vegetative state. The shortest period elapsed between the brain injury and pump implantation was three months and the longest period was nine years, mean 15 months. Baclofen pump had to be changed in six cases after six years, and was removed in three cases due to decreasing spasticity. Catheter revision was performed in two cases due to flow problem. We had no complication in association with ITB therapy. Conclusions - Intrathecal baclofen therapy seems to be an effective and safe treatment in patients with severe spasticity of cerebral origin. We suggest team (neurosurgeon and rehabilitation professionals) decision in a spasticity center before involving the patient into ITB therapy, and follow up in the rehabilitation unit. The severity of spasticity as a consequence of brain injury can change during years and it is necessery to follow it with dosage and dynamics of baclofen therapy. Baclofen pump removal is suggested if the ITB therapy is further not reasonable.

Original languageHungarian
Pages (from-to)243-247
Number of pages5
JournalIdeggyógyászati szemle
Volume65
Issue number7-8
Publication statusPublished - Jul 30 2012

Fingerprint

Baclofen
Brain Injuries
Therapeutics
Rehabilitation
Hungary
Persistent Vegetative State
Catheters
Retrospective Studies
Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Az intrathecalis baclofenkezelés tapasztalatai agyká rosodást szenvedett, spasticus felno{combining double acute accent}tt betegek esetében. / Dénes, Zoltán; Klauber, András; Both, Béla; Erőss, L.

In: Ideggyógyászati szemle, Vol. 65, No. 7-8, 30.07.2012, p. 243-247.

Research output: Contribution to journalArticle

@article{db52886d5d3e44b89d76a9584f418374,
title = "Az intrathecalis baclofenkezel{\'e}s tapasztalatai agyk{\'a} rosod{\'a}st szenvedett, spasticus felno{combining double acute accent}tt betegek eset{\'e}ben",
abstract = "Objectives - To evaluate the results of intrathecal baclofen (ITB) therapy on the spasticity in patients with brain injury. Method - Retrospective study in Brain Injury Rehabilitation Unit between January 2001 and December 2010. Results - During the last ten years, in our unit 13 patients were involved into ITB therapy on severe spasticity, after brain injury, while more than 100 Baclofen pumps were implantated in Hungary with Hungary with coordination of the Multidisciplinary Team. ITB therapy was indicated in severe spasticity developed after seven cases of traumatic brain injuries, five cases of strokes and one case of anoxic brain injury. The mean age of patients was 26 years (18-52). At the time of pump implantation three patients were in vegetative state. The shortest period elapsed between the brain injury and pump implantation was three months and the longest period was nine years, mean 15 months. Baclofen pump had to be changed in six cases after six years, and was removed in three cases due to decreasing spasticity. Catheter revision was performed in two cases due to flow problem. We had no complication in association with ITB therapy. Conclusions - Intrathecal baclofen therapy seems to be an effective and safe treatment in patients with severe spasticity of cerebral origin. We suggest team (neurosurgeon and rehabilitation professionals) decision in a spasticity center before involving the patient into ITB therapy, and follow up in the rehabilitation unit. The severity of spasticity as a consequence of brain injury can change during years and it is necessery to follow it with dosage and dynamics of baclofen therapy. Baclofen pump removal is suggested if the ITB therapy is further not reasonable.",
keywords = "Brain injury, Intrathecal baclofen therapy, Rehabilitation, Spasticity",
author = "Zolt{\'a}n D{\'e}nes and Andr{\'a}s Klauber and B{\'e}la Both and L. Erőss",
year = "2012",
month = "7",
day = "30",
language = "Hungarian",
volume = "65",
pages = "243--247",
journal = "Ideggyogyaszati Szemle",
issn = "0019-1442",
publisher = "Ifjusagi Lap-es Konyvkiado Vallalat",
number = "7-8",

}

TY - JOUR

T1 - Az intrathecalis baclofenkezelés tapasztalatai agyká rosodást szenvedett, spasticus felno{combining double acute accent}tt betegek esetében

AU - Dénes, Zoltán

AU - Klauber, András

AU - Both, Béla

AU - Erőss, L.

PY - 2012/7/30

Y1 - 2012/7/30

N2 - Objectives - To evaluate the results of intrathecal baclofen (ITB) therapy on the spasticity in patients with brain injury. Method - Retrospective study in Brain Injury Rehabilitation Unit between January 2001 and December 2010. Results - During the last ten years, in our unit 13 patients were involved into ITB therapy on severe spasticity, after brain injury, while more than 100 Baclofen pumps were implantated in Hungary with Hungary with coordination of the Multidisciplinary Team. ITB therapy was indicated in severe spasticity developed after seven cases of traumatic brain injuries, five cases of strokes and one case of anoxic brain injury. The mean age of patients was 26 years (18-52). At the time of pump implantation three patients were in vegetative state. The shortest period elapsed between the brain injury and pump implantation was three months and the longest period was nine years, mean 15 months. Baclofen pump had to be changed in six cases after six years, and was removed in three cases due to decreasing spasticity. Catheter revision was performed in two cases due to flow problem. We had no complication in association with ITB therapy. Conclusions - Intrathecal baclofen therapy seems to be an effective and safe treatment in patients with severe spasticity of cerebral origin. We suggest team (neurosurgeon and rehabilitation professionals) decision in a spasticity center before involving the patient into ITB therapy, and follow up in the rehabilitation unit. The severity of spasticity as a consequence of brain injury can change during years and it is necessery to follow it with dosage and dynamics of baclofen therapy. Baclofen pump removal is suggested if the ITB therapy is further not reasonable.

AB - Objectives - To evaluate the results of intrathecal baclofen (ITB) therapy on the spasticity in patients with brain injury. Method - Retrospective study in Brain Injury Rehabilitation Unit between January 2001 and December 2010. Results - During the last ten years, in our unit 13 patients were involved into ITB therapy on severe spasticity, after brain injury, while more than 100 Baclofen pumps were implantated in Hungary with Hungary with coordination of the Multidisciplinary Team. ITB therapy was indicated in severe spasticity developed after seven cases of traumatic brain injuries, five cases of strokes and one case of anoxic brain injury. The mean age of patients was 26 years (18-52). At the time of pump implantation three patients were in vegetative state. The shortest period elapsed between the brain injury and pump implantation was three months and the longest period was nine years, mean 15 months. Baclofen pump had to be changed in six cases after six years, and was removed in three cases due to decreasing spasticity. Catheter revision was performed in two cases due to flow problem. We had no complication in association with ITB therapy. Conclusions - Intrathecal baclofen therapy seems to be an effective and safe treatment in patients with severe spasticity of cerebral origin. We suggest team (neurosurgeon and rehabilitation professionals) decision in a spasticity center before involving the patient into ITB therapy, and follow up in the rehabilitation unit. The severity of spasticity as a consequence of brain injury can change during years and it is necessery to follow it with dosage and dynamics of baclofen therapy. Baclofen pump removal is suggested if the ITB therapy is further not reasonable.

KW - Brain injury

KW - Intrathecal baclofen therapy

KW - Rehabilitation

KW - Spasticity

UR - http://www.scopus.com/inward/record.url?scp=84865529673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865529673&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 243

EP - 247

JO - Ideggyogyaszati Szemle

JF - Ideggyogyaszati Szemle

SN - 0019-1442

IS - 7-8

ER -